RVMD: Revolution Medicines, Inc. Stock

by  •  • Comments Off on RVMD: Revolution Medicines, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 7,083.30
Enterprise Value ($M) 6,540.23
Book Value ($M) 2,265.20
Book Value / Share 12.18
Price / Book 3.13
NCAV ($M) 2,034.54
NCAV / Share 10.94
Price / NCAV 3.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.25
Return on Assets (ROA) -0.29
Return on Equity (ROE) -0.33

Liquidity (mrq)
Quick Ratio 14.20
Current Ratio 14.20

Balance Sheet (mrq) ($M)
Current Assets 2,327.63
Assets 2,558.30
Liabilities 293.10
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -689.52
Net Income -600.09

Cash Flow Statement (mra) ($M)
Cash From Operations -557.44
Cash from Investing -554.39
Cash from Financing 959.41

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Janus Henderson Group Plc 5.20
11-08 13G/A Wellington Management Group Llp 6.83 -23.39

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-28 193,043 657,626 29.35
2025-03-27 157,904 574,722 27.47
2025-03-25 198,902 654,244 30.40

(click for more detail)

Similar Companies
ROIV – Roivant Sciences Ltd. RPRX – Royalty Pharma plc
RPTX – Repare Therapeutics Inc. RXRX – Recursion Pharmaceuticals, Inc.
SANA – Sana Biotechnology, Inc.


Financial data and stock pages provided by
Fintel.io